Document Details
Form
Filing Date
Apr 22, 2024
Document Date
Apr 18, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EYEPOINT PHARMACEUTICALS, INC.
Filer
ADAGE CAPITAL MANAGEMENT, L.P.
